Total skin electron beam therapy for primary cutaneous T-cell lymphomas: clinical characteristics and outcomes in a Mexican reference center.

AIM: The aim of this study was to assess treatment modalities, treatment response, toxicity profile, disease progression and outcomes in 14 patients with a confirmed diagnosis of primary cutaneous T-cell lymphoma (PCTCL) treated with total skin electron beam therapy (TSEBT). BACKGROUND: Primary cutaneous lymphomas (PCLs) are extranodal non-Hodgkin lymphomas originating in the skin without evidence of extracutaneous disease at diagnosis. Despite advances in systemic and local therapy options, the management of advanced stages remains mostly palliative. MATERIALS AND METHODS: This is a retrospective study of patients with PCTCL, diagnosed and treated in a reference center in Mexico City, analyzing treatment modalities, response to treatment, long-term outcome, and mortality. RESULTS: Eight males (57%) and 6 (43%) females were identified. Most patients were stage IVA (n = 5, 36%) followed by stage IB and IIB (28.5% and 21.4%, respectively). Eleven patients received the low-dose RT scheme (12 Gy), 1 patient, the intermediate-dose RT scheme (24 Gy), and 2 patients, the conventional-dose RT scheme (36 Gy). Mean follow-up time was 4.6 years. At first follow-up examination, 6-8 weeks after radiotherapy, the overall response rate (ORR) for the cohort was 85%. The median PFS for the whole cohort was 6 months. CONCLUSION: This study reinforces the role of TSEBT when compared with other treatment modalities and novel agents. Low-dose TSEBT is now widely used because of the opportunity for retreatment.

Optically and thermally stimulated luminescence characteristics of LaAlO3:Pr3+ beta irradiated.

This paper reports on an investigation into the thermally stimulated luminescence (TL) and optically stimulated luminescence (OSL) characteristics of novel luminescent phosphor. A new Pr3+-doped, lanthanum aluminate (LaAlO3)-based luminescent phosphor is developed. Samples of LaAlO3:Pr3+ were irradiated to beta doses, in air, from 0.1Gy up to 50Gy and then were analyzed using both TL and continuous wavelength OSL (CW-OSL) techniques to determine their luminescent characteristics. This phosphor shows a TL glow curve, after its irradiation to beta radiation, with two TL peaks: one located around 160°C and a second at 300°C. CW-OSL response presented a fast decay into the first 20s of blue light stimulation. TL and CW-OSL response as a function of beta radiation dose were linear in the studied dose range. The high sensitivity of the CW-OSL and TL response will make this phosphor suitable for beta radiation detection. Finally, the kinetic parameters of activation energy, frequency factor and kinetic order were analyzed in the TL response using computerized glow curve deconvolution based on general order kinetic model.

Thermoluminescent dosimeters for low dose X-ray measurements.

The response of TLD-100, CaSO4:Dy and LiF:Mg,Cu,P for a range of X-ray low dose was measured. For calibration, the TLDs were arranged at the center of the X-ray field. The dose output of the X-ray machine was determined using an ACCU-Gold. All dosimeters were exposed at the available air kerma values of 14.69 mGy within a field 10×10 cm(2) at 80 cm of SSD. Results of LiF:Mg,Cu,P X-ray irradiated showed 4.8 times higher sensitivity than TLD-100. Meanwhile, TL response of CaSO4:Dy exposed at the same dose was 5.6 time higher than TLD-100. Experimental results show for low dose X-ray measurements a better linearity for LiF:Mg,Cu,P compared with that of TLD-100. CaSO4:Dy showed a linearity from 0.1 to 60 mGy.